Agata Szymaszkiewicz
Lodz, LD 92215, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
The role of bidirectional communication between the adipokines and the endogenous opioid system in an experimental mouse model of colitis-associated colorectal cancer.
Journal: Pharmacological reports : PR
Published: March 30, 2023
The Enteric Glia and Its Modulation by the Endocannabinoid System, a New Target for Cannabinoid-Based Nutraceuticals?
Journal: Molecules (Basel, Switzerland)
Published: July 01, 2022
The Involvement of the Endogenous Opioid System in the Gastrointestinal Aging in Mice and Humans.
Journal: International journal of molecular sciences
Published: January 27, 2022
Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disorders.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: November 10, 2021
Nutraceuticals and peripheral glial cells: a possible link?
Journal: Journal of integrative neuroscience
Published: July 28, 2021
Nutraceuticals and Enteric Glial Cells.
Journal: Molecules (Basel, Switzerland)
Published: April 15, 2021
Critical interactions between opioid and cannabinoid receptors during tolerance and physical dependence development to opioids in the murine gastrointestinal tract: proof of concept.
Journal: Pharmacological reports : PR
Published: January 27, 2021
New insights into molecular pathways in colorectal cancer: Adiponectin, interleukin-6 and opioid signaling.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: October 08, 2020
Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice.
Journal: European journal of pharmacology
Published: May 21, 2020
The place of sphingosine-1-phosphate modulators in the therapy of inflammatory bowel diseases
Journal: Postepy biochemii
Published: January 24, 2020
Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 02, 2019
Last Updated: 09/26/2026